Adaptimmune Therapeutics plc (ADAP)
NASDAQ: ADAP · IEX Real-Time Price · USD
1.170
-0.010 (-0.85%)
At close: Jul 19, 2024, 4:00 PM
1.080
-0.090 (-7.69%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Adaptimmune Therapeutics Market Cap
Adaptimmune Therapeutics has a market cap or net worth of $298.93 million as of July 22, 2024. Its market cap has increased by 94.36% in one year.
Market Cap
298.93M
Enterprise Value
176.11M
1-Year Change
94.36%
Ranking
Category
Stock Price
$1.17
Market Cap Chart
Since March 31, 2016, Adaptimmune Therapeutics's market cap has decreased from $575.60M to $298.93M, a decrease of -48.07%. That is a compound annual growth rate of -7.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 299.10M | 66.07% |
| Dec 29, 2023 | 180.10M | -24.71% |
| Dec 30, 2022 | 239.20M | -59.17% |
| Dec 31, 2021 | 585.90M | -29.78% |
| Dec 31, 2020 | 834.40M | 561.17% |
| Dec 31, 2019 | 126.20M | -79.02% |
| Dec 31, 2018 | 601.40M | -3.93% |
| Dec 29, 2017 | 626.00M | 118.35% |
| Dec 30, 2016 | 286.70M | -50.19% |
| Mar 31, 2016 | 575.60M | - |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jasper Therapeutics | 305.33M |
| Opthea | 305.22M |
| Enanta Pharmaceuticals | 303.29M |
| Atea Pharmaceuticals | 300.68M |
| SOPHiA GENETICS | 299.42M |
| Verrica Pharmaceuticals | 298.64M |
| Poseida Therapeutics | 296.69M |
| Tactile Systems Technology | 294.18M |